eye disease | pharmaphorum

Friday 5 December 2025

eye disease

News

eye

Oculis SA and EBAC join to drive ophthalmology innovation

Oculis SA, a global biopharmaceutical company that develops treatments for saving sight and improving eye care with breakthrough innovations, is to combine with the European Biotech Acquisi

Views & Analysis

Genetic testing hopes to speed up drug development in rare eye diseases

Genetic testing hopes to speed up drug development in rare e...

When it comes to fighting rare diseases, the biggest barrier to overcome is often the lack of knowledge around the condition.

News

FDA grants fast review for Horizon's rare eye disease drug

FDA grants fast review for Horizon's rare eye disease drug

The FDA has granted a fast review for Horizon Therapeutics’ teprotumumab for active thyroid eye disease (TED), a rare vision-threatening autoimmune condition.

News

eye

Syncona joins Gyroscope, Orbit to create eye gene therapy pl...

UK biotech Gyroscope Therapeutics is to merge with Orbit Biomedical of the US to create a specialist in gene therapies for eye diseases.

News

ocular disease

Ocugen, Histogenics merge to form eye disease specialist

US biotechs Ocugen and Histogenics have announced plans to merge, creating a specialist in drugs and gene therapies for ocular diseases.

News

NICE1

NICE rejects rare eye disease therapy

Other treatment option is disfiguring eyelid operation